CAJ | 학술논문

目前对焦虑障碍缺乏统一的诊断标准，国内外指南的分型和治疗用药不尽相同。一般认为焦虑障碍的一线用药为SSRIs、SNRIs，部分指南推荐普瑞巴林可以作为一线药物，难治性焦虑障碍可在抗抑郁药基础上加二线药物，或者非经典抗精神病药物、抗抽搐药物等，常规治疗时间一般在12～18个月，对于广泛性焦虑障碍（ gen eral-ized anxiety disorder ，GAD）甚至需要终身治疗。
목전대초필장애결핍통일적진단표준，국내외지남적분형화치료용약불진상동。일반인위초필장애적일선용약위SSRIs、SNRIs，부분지남추천보서파림가이작위일선약물，난치성초필장애가재항억욱약기출상가이선약물，혹자비경전항정신병약물、항추휵약물등，상규치료시간일반재12～18개월，대우엄범성초필장애（ gen eral-ized anxiety disorder ，GAD）심지수요종신치료。
Due to lack of uniform diagnostic criteria , the domestic and international cclassification and treatment guide-lines of anxiety disorders vary a lot currently .It is generally recognized that SSRIs and SNRIs are the first -line treatment of anxiety disorders.In addition, a minority of guidelines recommend pregabalin as the first -line drug.Refractory anxiety disorders can be treated by a combination of antidepressants with second -line drugs, non -classical antipsychotics or anti-convulsive drugs.Conventional treatment cycles are generally between 12 to 18 months.Lifelong treatment may be e-ven necessary for GAD .